Investors Capital Advisory Services’s PDL BioPharma, Inc. PDLI Stock Holding History

Investors Capital Advisory Services’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,706	Closed	-$94K	–	767
2015 Q3	$94K	Buy	18,706 +4,560	+32%	+$26.1K	0.02%	655
2015 Q2	$90K	Buy	14,146 +300	+2%	+$2.01K	0.02%	682
2015 Q1	$97K	Sell	13,846 -663	-5%	-$4.8K	0.02%	676
2014 Q4	$111K	Buy	14,509 +1,000	+7%	+$7.91K	0.02%	644
2014 Q3	$100K	Buy	13,509 +1,818	+16%	+$16.9K	0.02%	633
2014 Q2	$113K	Buy	11,691 +200	+2%	+$1.78K	0.02%	638
2014 Q1	$95K	Sell	11,491 -200	-2%	-$1.71K	0.02%	609
2013 Q4	$98K	Buy	11,691 +510	+5%	+$4.3K	0.02%	577
2013 Q3	$89K	Hold	11,181	–	–	0.02%	542
2013 Q2	$86K	Buy	+11,181	New	+$87.2K	0.03%	494

Other funds holding PDLI

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Investors Capital Advisory Services's PDLI Position: Q4 2015 in Review

Investors Capital Advisory Services sold out of PDL BioPharma, Inc. (PDLI) in Q4 2015, closing a stake of 18,706 shares — an estimated $94K sold.

Investors Capital Advisory Services first reported a position in PDLI in Q2 2013 and held it in 10 quarters. The position peaked at $113K in Q2 2014. 204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

Investors Capital Advisory Services reported no remaining PDL BioPharma, Inc. position as of Q4 2015 after selling out during the quarter.
Investors Capital Advisory Services sold 18,706 PDL BioPharma, Inc. shares in Q4 2015, an estimated $94K.
Investors Capital Advisory Services first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 10 quarters.
Investors Capital Advisory Services's PDL BioPharma, Inc. position peaked at $113K in Q2 2014.
204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Investors Capital Advisory Services's 13F filing for Q4 2015, filed 8 Feb 2016.